Radiotherapy with S-1 for the treatment of esophageal squamous cell carcinoma 75 years or older
IF-IMRT combined with S-1 is a promising regimen for elderly ESCC. And the radiotherapy dose of 50.4 Gy remains the standard dose for EPs with ESCC undergoing CCRT.
Authors
- Yiyu Guo (ORCID: https://orcid.org/0000-0001-8706-8435)
- Dayong Gu (ORCID: https://orcid.org/0000-0002-9547-8474)
- Ying Fang (ORCID: https://orcid.org/0000-0003-2485-8688)
- Jinjun Ye (ORCID: https://orcid.org/0000-0002-9529-7016)
- Guoren Zhou (ORCID: https://orcid.org/0000-0001-5344-8480)
- Qiang Wang (ORCID: https://orcid.org/0000-0003-3123-3889)
- Rongrong Zhang (ORCID: https://orcid.org/0000-0002-1228-9345)
- Zhi Zhang (ORCID: https://orcid.org/0000-0002-3222-2877)
- Daguang Wu
- Haifeng Shi
- Wei Chen (ORCID: https://orcid.org/0000-0002-3792-6638)
- Ying Liu (ORCID: https://orcid.org/0000-0002-7164-962X)
- Tian Wang (ORCID: https://orcid.org/0000-0002-6801-1502)
Institutions
- Jiangsu University (CN)
- Nanjing University of Chinese Medicine (CN)
- Xuzhou Cancer Hospital (CN)
- Jiangning District of Nanjing Chinese Medicine Hospital (CN)
- Jiangsu Cancer Hospital (CN)
- Yancheng Second People's Hospital (CN)
- Jingning County People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Radiation Oncology
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1186/s13014-024-02509-3
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Government of Jiangsu Province
- Wu Jieping Medical Foundation